Literature DB >> 137733

Structural study of pulmonary circulation and of heart in total anomalous pulmonary venous return in early infancy.

S G Haworth, L Reid.   

Abstract

Quantitative morphometric techniques have been applied to the injected and inflated lung and to the heart in 9 infants with total anomalous pulmonary venous return dying with obstruction to pulmonary venous return. In 5 (mean age at death 55 days) pge 20 days) to an infradiaphragmatic site. Structural changes were present in the pulmonary circulation in all patients, even in the youngest, an 8-day-old child. In both types of total anomalous pulmonary venous return increased arterial muscularity was severe, as shown by increase in wall thickness and by extension of muscle into smaller and more peripheral arteries than normal; these changes tended to increase with age. Where the pulmonary venous blood drained to a supradiaphragmatic site, the severity of arterial medial hypertrophy correlated inversely with the magnitude of the pulmonary: systemic flow ratio, increasing as the pulmonary blood flow fell. Vein wall thickness was increased and in all but the youngest child the veins were 'arterialised'. At the lung periphery the arteries and alveoli appeared to have multiplied normally. Arterial size varied according to whether pulmonary venous blood drained above or below the diaphragm; the diameter of pre- and intra-acinar arteries was increased only in cases where the pulmonary venous return drained to a supradiaphragmatic site, being normal when it drained to an infradiaphragmatic site. In the heart the left ventricle was of normal size in all but one case. Dilation and severe hypertrophy of the right ventricle and septum were present only in cases of drainage to a supradiaphragmatic site. In the older patients with the latter anomaly dilation of the pulmonary arteries and right ventricle suggested that a large left-to-right shunt had preceded the onset of obstruction to pulmonary venous return and that the more severe right ventricular and septal hypertrophy in these cases might be the result of a longer duration of pulmonary hypertension. In contrast, in total anomalous pulmonary venous return to an infradiaphragmatic site it appears that obstruction to pulmonary venous return develops soon after birth and prevents a large increase in pulmonary blood flow, and thus neither the pulmonary arteries nor the right ventricle become dilated. In infants with total anomalous pulmonary venous return and obstruction to pulmonary venous return, it is striking how rapidly the pulmonary circulation develops new muscle.

Entities:  

Mesh:

Year:  1977        PMID: 137733      PMCID: PMC483198          DOI: 10.1136/hrt.39.1.80

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  29 in total

1.  Total anomalous pulmonary venous connection with severe pulmonary venous obstruction. A clinical entity.

Authors:  A R HASTREITER; M H PAUL; M E MOLTHAN; R A MILLER
Journal:  Circulation       Date:  1962-06       Impact factor: 29.690

2.  A qualitative and quantitative study of the ventricles and great vessels of normal children.

Authors:  M V DE LA CRUZ; G ANSELMI; A ROMERO; G MONROY
Journal:  Am Heart J       Date:  1960-11       Impact factor: 4.749

3.  Total anomalous pulmonary venous connection.

Authors:  J T BURROUGHS; J E EDWARDS
Journal:  Am Heart J       Date:  1960-06       Impact factor: 4.749

4.  Total anomalous pulmonary venous drainage: clinical and physiologic patterns.

Authors:  H B BURCHELL
Journal:  Proc Staff Meet Mayo Clin       Date:  1956-03-21

5.  Significance of the pulmonary vascular bed in congenital heart disease. V. Lesions of the left side of the heart causing obstruction of the pulmonary venous return.

Authors:  C FERENCZ; J F DAMMANN
Journal:  Circulation       Date:  1957-12       Impact factor: 29.690

6.  Infradiaphragmatic total anomalous pulmonary venous connection.

Authors:  A L JOHNSON; F W WIGLESWORTH; J S DUNBAR; S SIDDOO; M GRAJO
Journal:  Circulation       Date:  1958-03       Impact factor: 29.690

7.  Morphologic changes in intrapulmonary veins.

Authors:  C A Wagenvoort
Journal:  Hum Pathol       Date:  1970-06       Impact factor: 3.466

8.  New pathological findings in emphysema of childhood. 1. Polyalveolar lobe with emphysema.

Authors:  A Hislop; L Reid
Journal:  Thorax       Date:  1970-11       Impact factor: 9.139

9.  Total anomalous pulmonary venous return. Correlation of hemodynamic observations and surgical mortality in 58 cases.

Authors:  R D Leachman; D A Cooley; G L Hallman; J W Simpson; W E Dear
Journal:  Ann Thorac Surg       Date:  1969-01       Impact factor: 4.330

10.  Arterial changes in the lungs in cirrhosis of the liver--lung spider nevi.

Authors:  P Berthelot; J G Walker; S Sherlock; L Reid
Journal:  N Engl J Med       Date:  1966-02-10       Impact factor: 91.245

View more
  5 in total

1.  Growth and development of pulmonary circulation in pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries.

Authors:  S G Haworth; F J Macartney
Journal:  Br Heart J       Date:  1980-07

2.  [Surgical treatment of total anomalous pulmonary venous connection--clinical aspects of pulmonary venous obstruction].

Authors:  K Yoshihara; T Ozawa; H Sakuragawa; T Fujii; N Shiono; Y Watanabe; N Koyama; H Matsuura; T Saji; Y Takanashi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-11

3.  Cor triatriatum masked by primary pulmonary hypertension.

Authors:  D Lang; C A Wagenvoort; C Kupferschmid; E Kleihauer
Journal:  Pediatr Cardiol       Date:  1985       Impact factor: 1.655

4.  Total anomalous pulmonary venous return. Prenatal damage to pulmonary vascular bed and extrapulmonary veins.

Authors:  S G Haworth
Journal:  Br Heart J       Date:  1982-12

5.  Total anomalous pulmonary venous connection. Repair using deep hypothermia and circulatory arrest in 44 consecutive infants.

Authors:  D F Dickinson; K M Parimelazhagan; M C Tweedie; C R West; G P Piccoli; F Musumeci; D I Hamilton
Journal:  Br Heart J       Date:  1982-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.